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HISTORICAL BACKGROUND 
(BEFORE THE XX CENTURY)
The concept of “apoptosis” can be found in chap-ter 35 of Hippocrates’ Mochlicon (V-IV cen-
tury B.C.), a treatise concerning the reduction of
dislocations, in which the gangrene resulting from
the treatment of fractures by means of bandages is
reported and described (1,2). The idea of apopto-
sis was consequently already implied by Hippo-
crates to indicate what today is considered the phy-
siological destruction of cells and tissues. Areteus
of Cappadocia in the I century A.D. and Galen of
Pergamus in the II gave ulterior and better elabo-
ration to the concept of “necrosis”, and the term
was fully defined by Rudolph Virchow, the great
German pathologist, in the XIX century (3). In
1858, in his 15th lecture, Virchow described two
types of cell death, necrobiosis and necrosis. Ne-
crobiosis is “always here to deal with a gradual de-
cay and death, a dissolution… Necrobiosis is death
brought on by (altered) life, a spontaneous wearing
out of living parts, the destruction and annihilation
consequent on life, natural as opposed to violent
death (mortification)… But the idea of necrosis
really does not offer any analogy to these proces-
ses” (4,5). In effect, Virchow called necrobiosis
what we today call apoptosis, specifically distin-
guishing it from true necrosis; he applied the term
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RIASSUNTO
Anche se il concetto di apoptosi può essere probabilmente rintracciato per la prima volta in un trattato ippocratico,
fu Rudolph Virchow, il padre della patologia cellulare, a dare la prima descrizione strutturata, nel XIX secolo, dei
processi sottostanti il termine apoptosi.
Nel corso del XX secolo è stato costruito un patrimonio di osservazioni sistematiche riguardanti la morte cellulare.
Nel 1908 Mechnikov vinse il Premio Nobel per i suoi studi sulla fagocitosi, mentre negli anni ’30 e ’40 furono con-
dotti molti studi sulla metamorfosi, e Fell e Canti individuarono la morte cellulare in condrociti in cultura. Alla fine
degli anni ’40 Saunders diede inizio alle sue osservazioni sulla morte cellulare negli arti del pulcino, e Hamburger e
Levi Montalcini avviarono le loro ricerche sui fattori di crescita nervosa. Intorno alla metà degli anni ’50 cominciò
lo studio dei lisosomi, e negli anni ’60 Kerr definì la necrosi da contrazione. Il termine apoptosi fu introdotto e diffu-
so definitivamente dallo stesso Kerr nel 1972 per indicare una particolare forma di morte nella quale le cellule si sui-
cidano disgregandosi in corpi apoptotici legati alle membrane. Negli anni ’80 fu descritto il ced-3 ed all’inizio degli
anni ’90 furono identificati i geni dell’apoptosi.
Più recentemente nuovi strumenti hanno consentito la descrizione di un ampio spettro di morte cellulare, compresa
l’apoptosi modernamente intesa. Il suo ruolo e la sua funzione in molte malattie differenti appare oggi di notevole in-
teresse, ed in particolare in quelle reumatiche evidenze recenti suggeriscono che, lungi dall’essere un percorso sem-
plice, breve e monomorfico, l’apoptosi è al contrario un processo complesso, lungo e pleiomorfico.
The historical evolution of the concept of apoptosis 
in rheumatic diseases
Evoluzione storica del concetto di apoptosi nelle malattie reumatiche
A.A. Conti1,2, D. Lippi3, G.F. Gensini1,2
1Department of Critical and Surgical Health Care, University of Florence, Florence;
2Don Carlo Gnocchi Foundation, IRCCS Florence;
3Department of Anatomy, Histology and Legal Medicine, University of Florence, Florence
 
necrosis to a specific type of cell degeneration,
whose fundamental characteristic was a striking
tissue collapse accompanied nevertheless by the
maintenance of the outer form of the dead tissues.
Instead, he adopted the term necrobiosis from
Schultz (6), to describe cell degeneration in those
cases in which it was impossible to identify the
previous structure of the tissues involved. In Vir-
chow’s view, in the presence of necrobiosis, cells
undergo a process of tissue softening and disinte-
gration with the consequence that the “mortified
section” completely disappears, and may only be
repaired by its replacement from nearby tissues.
What Virchow termed a softening of tissues is to-
day retained to be the result of the action of cel-
lular enzymes which cause the colliquative necro-
sis of dead tissues. His two descriptions of cell
death, necrosis and necrobiosis, currently fit the
models of limb gangrene and of brain colliquati-
ve necrosis respectively. 
The word apoptosis has been found cited in a XIX
century Spanish medical dictionary by Fernandez-
Flores and coworkers (2,7), and at the end of the
XIX century different types of cell death were ob-
served, even if many scientists seemed to be more
interested in phagocytosis than in necrobiosis or
apoptosis (8).
Julius Cohnheim was the author of the successive
description of cellular death (9); taking into ac-
count the observations performed by Carl Weigert
by means of the light microscope (10) he intro-
duced the term coagulation necrosis. Weigert had
discovered a notable fibrin impregnation in the ep-
ithelium of the trachea and the bronchi of patients
with diphtheria, even if it was later demonstrated
that the fibrin component was not related to tissue
coagulation. The research of Weigert determined
a massive increase in the studies on cell death, and
in the last decade of the XIX century a number of
other terms were used, so as to adapt language to
the new pathological conditions, thus contributing
to the detection of the different characteristic fea-
tures of nuclear necrotic degeneration, such as
karyolysis and karyorrhexis. By means of a cam-
era lucida, in 1885 Flemming was able to identi-
fy a specific type of the alteration of nuclei, nam-
ing it “chromatolysis”, since it dealt with the rup-
ture and the following disappearance of the cells
of the regressive ovarian follicle. Flemming accu-
rately described the presence of half moons of het-
erochromatin along the nuclear envelope, and the
successive rupture of nuclei surrounded by a rim
of cytoplasm in the cavity of the follicle (11).
Flemming’s observations are still today included
among the first descriptions of the modifications
typical of apoptotic cell death.
XX CENTURY DEVELOPMENTS
Nowadays the field of apoptosis is one of the most
studied in biology and medicine and accounts for
more than 2% of all life science publications an-
nually (12). Currently the term apoptosis refers to
a special morphology in which chromatin con-
denses or coalesces to heterochromatin in one or
more masses in the nucleus; it usually settles along
the still intact nuclear membrane (8). This defini-
tion derives from a long process of research car-
ried out during the XX century, and whose major
achievements have permitted the knowledge we
have today.
In spite of the major results of the XIX century in
the context of necrosis and necrobiosis, to use Vir-
chow’s terms, at the beginning of the XX century
cell death continued to remain a topic of interest
only in such closed fields as insect physiology.
However, Ilya Mechnikov won the Nobel Prize in
1908 for his discovery of phagocytosis, while in
1910 Charles Pérez published a treatise on the
metamorphosis of the blowfly Calliphora erythro-
cephala, underlining his conviction that the larva
were destroyed by phagocytes (13). 
The studies of Graeper in 1914, focusing on the
development of the yolk sac, established the need
for the presence of chromatolysis in the cells that
were to be deleted, disclosing that neighbouring
cells were able to absorb the cell debris (14). How-
ever, the term chromatolysis remained in the use
of the period, since the relevant confirmation by
Graeper was not appropriately appreciated by the
scientific community; in particular neuropatholo-
gists continued to adopt the same term in order to
describe a completely different condition, repre-
sented by the apparent collapse of Nissl substance
after the transection of the axon. 
In effect in the first years of the XX century the
attempts to define the mechanisms of cell death
were still neither numerous nor systematic in their
methodological approach. The systematists tried to
catalogue deaths in an effort to derive scientific
meaning from the large amount of confused data
available, until  Glucksmann (15) described in an
organic way different types of cell death, among
them nuclear fragmentation (karyorrhexis) and the
apoptotic appearance of nuclei (karyopyknosis).
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Glucksmann also recognized that cell death was
useful not only from the perspective of histio-
genetic and phylogenetic developments, but from
morphogenetic ones as well.
In the middle fifties, De Duve discovered the lyso-
somes, and this achievement led the researcher to
propose that cells may die by means of the explo-
sion of their lysosomes (16). The studies of De
Duve were very relevant in the perspective of a
better comprehension of the existence of addi-
tional, non-accidental types of cell demise.  
During the sixties the embryologist J.W. Saunders
identified reproducible patterns of cell death in
chick embryos, while different insect physiolo-
gists started the examination of metamorphic cell
deaths occurring after pupation (17). Saunders had
reported the presence of a posterior necrotic area
in the axilla of chick limbs and he demonstrated
that explanted posterior necrotic area cells would
die on schedule in culture. However, they could be
saved if transplanted to the back of different chick
embryos, thus suggesting the availability of a con-
trolled regulation of cell death. During the same
period, R.A. Lockshin began to refer to “pro-
grammed cell death”, with the meaning that cells
had a sequence of highly regulated steps towards
their own destruction (8), and both Saunders’s and
Lockshin’s discoveries made the possibility of
control of cell death a reality; afterwards, they fo-
cussed on the fact that cells remained functional
in the early part of their involution. 
APOPTOSIS AND RHEUMATIC DISEASES
In 1972 J.F.R. Kerr introduced the term apoptosis
to indicate a mechanism of “controlled cell dele-
tion”, which seemed “to play a complementary but
opposite role to mitosis in the regulation of animal
cell population” (18). In Kerr’s view this mode of
cell death foresaw two different phases, repre-
sented by the degradation of the nucleus and the
cytoplasm into apoptotic bodies bound to the
membranes and by the subsequent assimilation of
these same bodies on the part of other cells. Apop-
tosis appeared to occur in different processes,
among them the physiologic development of em-
bryos and the loss of cells in the course of tumoral
growth. Kerr underlined the function of the so-
called “intrinsic clock”, contemporaneously
proposing the role of a genetic element in the
process and correctly estimating the relevance of
environment in the regulation of apoptosis. A ge-
netic program was therefore retained to be present
both in the so-called “programmed cell death” and
in the apoptosis process, and this fact sometimes
generated misunderstanding in the use of the two
expressions. It has consequently recently been
pointed out that the term apoptosis ought to be
used to describe a situation in which the tools for
instant suicide are well defined and specified,
while “programmed cell death” should be used to
indicate a death on schedule in which the time
to/of death is specified (19). 
In effect in the course of time the different authors
researching in the cell death field have elaborated
a paradigm shift, switching from one in which
apoptosis and necrosis were considered well dis-
tinguished types of cell demise from a morpho-
logical and biochemical standpoint, to one in the
context of which the two cell death modalities are
an integral part of a same spectrum of cell death,
sharing common characteristics. In this recent ap-
proach “pure” necrosis and “pure” apoptosis are
the extremes of a continuous array of aponecrotic
responses, and it should be stressed that a blend of
characteristics related to both necrosis and apop-
tosis constitutes the far more usual response of tis-
sues and cells to damaging stimuli. The conse-
quence of such an integrated system and view is
that this new concept of cell death in apoptosis
has major implications both for the full compre-
hension of the physiologic patterns of apoptosis,
and for its deranged manifestations,the latter
prompted by its deregulation in human pathology
(20), and, in particular, in rheumatic diseases. In
this area basic research in apoptosis has concen-
trated on three major features: the selection of new
lymphocytes before antigen challenge; the control
of clonal expansion and resolution, with the in-
corporation of the destruction of apoptotic cells;
the selection of memory cells (21,22). 
With regard to systemic lupus erythematosus, mul-
tiple defects in the clearance of apoptotic materi-
al have been demonstrated, and many authors
therefore suggest that failure of clearance is at the
heart of the pathology (23). In effect diminuished
clearance of dying cells on the part of
macrophages, together with augmented apoptosis,
determine an accumulation of cellular fragments
in many different tissues. This process appears to
provoke the uptake of autoantigens from apoptot-
ic nuclei by dendritic cells. These cells then dis-
play modified self-epitopes to naïve T cells, and,
consequently, autoreactive T cells become acti-
vated. These furnish help for B cells which present
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peptides processed from the recent apoptotic at-
tack. Insufficient phagocytic removal of early
apoptotic cells can determine an accumulation of
necrotic cells and debris in the germinal centers of
secondary lymph organs. Furthermore B cells may
come into contact with intracellular autoantigens
released during the late stages of apoptotic cell
death and may become immobilised by follicular
dendritic cells. 
With reference to osteoarthritis, a number of recent
studies have demonstrated that apoptotic cell death
takes place at an increased rate in osteoarthritic
cartilage (24). Even if researchers must still un-
dertake hard work to understand  the mechanisms
underlying the process of complete cell death in
cartilage destruction, a satisfactory level of com-
prehension of the extent of cell death in the patho-
logic process has already been achieved, and in
this context apoptotic phenomena appear to be
consistent and relevant. 
In rheumatoid arthritis a full understanding of the
mechanisms involved in the resistance to apopto-
sis of synovial macrophages and fibroblasts is
mandatory to elucidate the processes that con-
tribute to the perpetuation of the disease, as well
as to trace targets for new and effective therapies.
Whether apoptosis in rheumatoid arthritis is a
friend or foe is still unclear at present (25); how-
ever, to prevent pharmacological toxicity, which is
also prompted by the triggering of apoptosis, the
patterns of expression of the latter need to be care-
fully identified and explained. 
Recent studies suggest that one of the pathologic
cascades that lead to damage related to SSA/Ro-
SSB/La-associated congenital heart block can be
initiated by means of apoptosis resulting in the
translocation of SSA/Ro-SSB/La antigens with
consequent surface binding by maternal autoanti-
bodies (26). The eccessive apoptosis observed in
autopsy slides from fetuses with congenital heart
block may effectively provide an essential clue to
the understanding of the pathogenicity of mater-
nal autoantibodies. 
In summary, in rheumatic diseases, differently
from other clinical pathological conditions, cell
death, far from being the end of pathologies, of-
ten constitutes their beginning (27). Recent data in
rheumatology provide evidence that cell death is
a long-lasting, complex and pleiomorphic process,
during which cells gain novel functions and activ-
ities, initiating (auto)immunological events pro-
voking disease. An overview on apoptotic cells in
rheumatic pathologies therefore provides a new
stimulating perspective on “life” and “death” in the
course of pathological processes, since the pres-
ence of dead cells, rather than the absence of liv-
ing cells, is, in these cases, fundamental for patho-
genesis. 
CONCLUSIONS
The historical evolution of the concept of apopto-
sis appears stimulating because many “different”
phases of its history have followed each other in
time and each of them has been related to a specific
stage of knowledge. Even if the idea of apoptosis
may probably be detected as far back as in a Hip-
pocratic treatise, it was only Rudolph Virchow in
the XIX century who gave the first structured de-
scription of the processes underlying the term (28),
while in the course of the XX century a body of
systematic observations was elaborated on cell
death in an organic way: from the studies of Mech-
nikov on phagocytosis to the research of Fell and
Canti on metamorphosis, from the observations of
Saunders on cell death in chick limbs to Deduve’s
studies on lysosomes, from Hamburger’s explo-
ration of nerve growth factors to the definition of
shrinkage necrosis by Kerr. In very recent times
new instruments have permitted the description of
a wide range of cellular death, including apoptosis
as currently defined. Its role and function in many
different pathologies appear of specific interest; in
particular, in rheumatic diseases, extremely recent
evidence indicates that, far from being simple, brief
and monomorphic, apoptosis is a complex, long-
lasting, and pleiomorphic process.
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